Of note, our evaluated median symptom-free survival was comparable to Hambardzumyan et al., who primarily evaluated the tumor-formation capacity of RCAS-PDGFB in transgenic mice depending on the cerebral implantation site [46]. The gene discussed is PDGFB; the disease is neoplasm.